These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 29894004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations.
    Karalis V, Macheras P, Bialer M.
    CNS Drugs; 2014 Jan; 28(1):69-77. PubMed ID: 24092569
    [Abstract] [Full Text] [Related]

  • 3. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F, Duh MS, Gosselin A, Paradis PE.
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M, Midha KK.
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [Abstract] [Full Text] [Related]

  • 9. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E, Albani F, Capovilla G, Bernardina BD, Michelucci R, Zaccara G.
    Epilepsia; 2006 Jun; 47 Suppl 5():16-20. PubMed ID: 17239100
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.
    Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH.
    Drugs; 2010 Mar 26; 70(5):605-21. PubMed ID: 20329806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ, Gross RA, Tomaszewski KJ, Zingaro WM, Haskins LS.
    Neurology; 2008 Aug 12; 71(7):525-30. PubMed ID: 18695164
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessing bioequivalence of generic modified-release antiepileptic drugs.
    Johnson EL, Chang YT, Davit B, Gidal BE, Krauss GL.
    Neurology; 2016 Apr 26; 86(17):1597-604. PubMed ID: 27016518
    [Abstract] [Full Text] [Related]

  • 18. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR, Vinks AA, Fukuda T, Mizuno T, King EC, Zou Y, Jiang W, Woodle ES, Tremblay S, Klawitter J, Klawitter J, Christians U.
    PLoS Med; 2017 Nov 26; 14(11):e1002428. PubMed ID: 29135993
    [Abstract] [Full Text] [Related]

  • 19. Understanding therapeutic equivalence in epilepsy.
    Sankar R, Glauser TA.
    CNS Spectr; 2010 Feb 26; 15(2):112-23. PubMed ID: 20414156
    [Abstract] [Full Text] [Related]

  • 20. Generic substitution of antiepileptic drugs.
    Sander JW, Ryvlin P, Stefan H, Booth DR, Bauer J.
    Expert Rev Neurother; 2010 Dec 26; 10(12):1887-98. PubMed ID: 21091318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.